Trial intelligence / Profile preview

Daptomycin vs Vancomycin for Prophylaxis in Joint Arthroplasty

NCT01196169Phase 4Terminated

Sponsor
Mountain Home Research and Education Corporation
Start
Oct 2010
Primary completion
Mar 2014
Modality
Cyclic Peptides, Antimicrobial Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of daptomycin in surgical site infection (SSI), prosthetic joint infection (PJI), sponsored by Mountain Home Research and Education Corporation. Started Oct 2010; status: terminated.

02

Drugs

daptomycin
03

Conditions

surgical site infection (SSI)prosthetic joint infection (PJI)

Beyond the preview

Go deeper on NCT01196169.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01196169.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call